These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15686175)

  • 1. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system.
    Sasaki T; Kodama N; Kawakami M; Sato M; Asari J; Sakurai Y; Watanabe K; Onuma T; Matsuda T
    Stroke; 2000 Jun; 31(6):1256-62. PubMed ID: 10835441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.
    Kodama N; Sasaki T; Kawakami M; Sato M; Asari J
    Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage.
    Kawamoto S; Tsutsumi K; Yoshikawa G; Shinozaki MH; Yako K; Nagata K; Ueki K
    J Neurosurg; 2004 Feb; 100(2):236-43. PubMed ID: 15086230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Moriyama E; Matsumoto Y; Meguro T; Kawada S; Mandai S; Gohda Y; Sakurai M
    Neurol Med Chir (Tokyo); 1995 Oct; 35(10):732-6. PubMed ID: 8532128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage.
    Kawada S; Kinugasa K; Meguro T; Hirotsune N; Tokunaga K; Kamata I; Nakashima H; Ohmoto T
    Acta Neurochir (Wien); 1999; 141(12):1331-8. PubMed ID: 10672305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage.
    Otawara Y; Ogasawara K; Kubo Y; Sasoh M; Ogawa A
    Vasc Health Risk Manag; 2007; 3(4):401-4. PubMed ID: 17969369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ventriculo-cisternal irrigation on prevention of delayed cerebral infarction in aneurysmal subarachnoid hemorrhage: a single-center retrospective study and literature review.
    Umekawa M; Yoshikawa G
    Neurosurg Rev; 2023 Dec; 47(1):6. PubMed ID: 38062206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical procedure and results of cisternal washing therapy for the prevention of cerebral vasospasm following SAH.
    Nakagomi T; Furuya K; Nagashima H; Tanaka J; Ishii T; Takanashi S; Shinohara T; Watanabe F; Ogawa A; Fujii N; Tamura A
    Acta Neurochir Suppl; 2011; 110(Pt 2):105-9. PubMed ID: 21125454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
    Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
    Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive effect on intracranial arterial vasospasm using combined ventriculo-cisternal and cisternal drainage (author's transl)].
    Sonobe M; Takahashi S; Otsuki T; Kubota Y
    No Shinkei Geka; 1981 Nov; 9(12):1393-7. PubMed ID: 7322267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous cisternal drainage on cerebral vasospasm.
    Inagawa T; Kamiya K; Matsuda Y
    Acta Neurochir (Wien); 1991; 112(1-2):28-36. PubMed ID: 1763681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
    Kawano T; Kazekawa K; Nakashima S; Kohno H; Tanaka N; Honma T; Kaneko Y; Satoh K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.